Back to Journal

Home»Articles»Negligible Protection of Pancreas by Topical Curcumin in Streptozotocin Induced Diabetic Wounded Rats

JournalCover

Asian Journal of Science and Applied Technology (AJSAT)

Editor Dr. Balaji Ramachandran
Print ISSN : 2249 - 0698
Frequency : Half-yearly

Negligible Protection of Pancreas by Topical Curcumin in Streptozotocin Induced Diabetic Wounded Rats

Author : Vinay Kant, Dinesh Kumar1, Vijayta Gupta, and Babu L Jangir
Volume 9 No.1 January-June 2020 pp 10-13

Abstract

Damage or non-functioning of beta cells of Langerhans is lets of pancreas causes Type I diabetes. Curcumin, a bioflavonoid, have shown some tissue regenerative properties. It has shown a very good wound healing actions in diabetic animals after topical applications. In view of this, we planned to study the regenerative action of curcumin on damaged pancreas of diabetic rats after its topical applications on wounds. Damage of pancreas and induction of Type I diabetes in rats was achieved by single intraperitoneal injection of streptozotocin (60mg/kg b.wt.). Thereafter, open excisional wounds were created and wounded rats were divided into three groups viz. i) healthy control (non-diabetic), ii) Diabetic control and iii) Diabetic-treated. Pluronic F-127 gel (25%) was applied topically on wounds of group I and II once daily for 19 days. Curcumin (0.3%) in gel was topically applied similarly on group III. Average body weight gain was less and blood glucose levels were high in group II and III. There were also higher levels of MDA in group II and III. Histopathologically, atrophy and loss of intactness of beta cells of langerhans is lets in the pancreas were evident in group II and III, as compared to group I. In conclusion, topical applications of curcumin on wounds of diabetic rats did not able to prevent the damage of beta cells of the pancreas produced by single intraperitoneal injection of streptozotocin (60mg/kg b.wt.). In future, the other higher or lower concentrations of curcumin and their nano-formulations may be tried to evaluate the protective actions.

Keywords

Streptozotocin, Pancreas, Curcumin, Wound

Full Text:

References

  1. Hoenig, “Comparative aspects of diabetes mellitus in dogs and cats”, Molecular and Cellular Endocrinology, Vol. 197, pp. 221–229, 2002.
  2. Elias, H. Prigozin, N. Polak, M. Rapoport, A. W. Lohse, and I. R. Cohen, “Autoimmune diabetes induced by the b-Cell toxin STZ”, Diabetes, Vol. 43, pp. 992–998,1994.
  3. Hayashi, K. Kawakami, K. Ito, K. Ishii, H. Tanno, Y. Imai, E. Kanno,  R. Maruyama, H. Shimokawa, and M. Tachi, “Low-energy extracorporeal shock wave therapy enhances skin wound healing in diabetic mice: A critical role of endothelial nitric oxide synthase”, Wound Repair and Regeneration, Vol. 20, pp. 887–895, 2012.
  4. Takeshita, M. Kodama, H. Yamamoto, Y. Ikarashi, S. Ueda, T. Teratani, Y. Yamamoto, T. Tamatani, S. Kanegasaki, T. Ochiya, and G. Quinn, “Streptozotocin-induced partial beta cell depletion in nude mice without hyperglycaemia induces pancreatic morphogenesis in transplanted embryonic stem cells”, Diabetologia, Vol. 49, pp. 2948–2958, 2006.
  5. Soudamani, T. Malini, and K. Balasubramanian, “Effects of streptozotocin-diabetes and insulin replacement on the epididymis of prepubertal rats: histological and histomorphometric studies”, Endocrine Research, Vol. 31, pp. 81–98, 2005.
  6. Mishra, H. Kumar, and K.Tripathi, “Diabetic delayed wound healing and the role of silver nanoparticles”, Digest Journal of Nanomaterials and Biostructures, Vol. 3, pp. 49–54, 2008.
  7. , King, R. E. Aubert, and W. H. Herman, “Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections”, Diabetes Care, Vol. 21, pp. 1414–1431, 1998.
  8. W. Logerfo, and J. D. Coffman, “Vascular and microvascular disease of the foot in diabetes. Implications for foot care”, New England Journal of Medicine, Vol. 311, pp. 1615–1619, 1984.
  9. Shukla, and R. Mani, “Emerging trends in diabetic foot ulcer management in India”, International Journal of Lower Extremity Wounds, Vol. 9, pp. 111–112, 2010.
  10. S. Wright, “Predicting the antioxidant activity of curcumin and curcuminoids”, Journal of Molecular Structure: THEOCHEM, Vol. 591, pp. 207–217, 2002.
  11. S. Sidhu, A. K. Singh, D. Thaloor, K. K. Banaudha, G. K. Patnaik, R. C. Srimal, and R. K. Maheshwari, “Enhancement of wound healing by curcumin in animals”, Wound Repair Regeneration, Vol. 6, pp. 167–177, 1998.
  12. Mani, G. S. Sidhu, R. Kumari, J. P. Gaddipati, P. Seth, and R. K. Maheshwari, “Curcumin differentially regulates TGF-beta1, its receptors and nitric oxide synthase during impaired wound healing”, Biofactors, Vol. 16, pp. 29–43, 2002.
  13. C. Jagetia, and G. K. Rajanikant, “Acceleration of wound repair by curcumin in the excision wound of mice exposed to different doses of fractionated c radiation”, International Wound Journal, Vol. 9, pp. 76–92, 2012.
  14. Shafiq-Ur-Rehman. “Lead-induced regional lipid peroxidation in brain”, Toxicology Letters, 21, pp. 333-337, 1984.
  15. Ikebukuro, Y. Adachi, Y. Yamada, S. Fujimoto, Y. Seino, and H. Oyaizu, “Treatment of streptozotocin-induced diabetes mellitus by transplantation of islet cells plus bone marrow cells via portal vein in rats”, Transplantation, Vol. 73, pp. 512–518, 2002.
  16. Elsner, B. Guldbakke, M. Tiedge, R. Munday, and S. Lenzen, “Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin”, Diabetologia, Vol. 43, pp. 1528–1533, 2000.
  17. Szkudelski, “The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas”, Physiological Research, Vol. 50, pp. 537–546, 2001. 
  18. Wang,L. A. Muffley, K. Hall,  M. Chase, and N. S. Gibran,  “Elevated glucose and fatty acid levels impair substance P-induced dermal microvascular endothelial cell migration and proliferation in an agarose gel model system”, Shock, Vol. 32, pp. 491–497, 2009.
  19. Khanna, “Turmeric -nature’s precious gift”, Current Science, Vol. 76, pp. 1351–1356, 1999.
  20. P. Lim, T. Chu, F. Yang, W. Beech, S. A. Frautschy, and G. M. Cole, “The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgene mouse”, Journal of Neuroscience, Vol. 21, pp. 8370–8377, 2001.
  21. Kloesch, T. Becker, E. Dietersdorfer, H. Kiener, and G. Steiner, “Anti-inflammatory and apoptotic effects of the polyphenol curcumin on human fibroblast-like synoviocytes”, International Immunopharmacology, Vol. 15, pp. 400–405, 2013.
  22. R. C. Barclay, M. R. Vinqvist, K. Mukai, H. Goto, Y. Hashimoto, A. Tokuanga and H. Uno, “The antioxidant mechanism of curcumin: Classical methods are needed to determine antioxidant mechanism and activity”, Organic Letters, Vol. 2, pp. 2841–2843, 2000.
  23. I. Priyadarsini, D. K. Maity, G. H. Naik, M. S. Kumar, M. K. Unnikrishnan, J. G. Satav, and H. Mohan, “Role of phenolic O:H and methylene hydrogen on the free 120 Menon and Sudheer radical reaction and antioxidant activity of curcumin”, Free Radical Biology and Medicine, Vol. 35, pp. 475–484, 2003.
  24. P. Menon, and A. R. Sudheer, “Antioxidant and anti-inflammatory properties of curcumin”, Advances in Experimental Medicine and Biology, Vol. 595, pp. 105–125, 2007.
  25. L. Thangapazham, A. Sharma, and R. K. Maheshwari, “Beneficial role of curcumin in skin diseases”, Advances in Experimental Medicine and Biology, Vol. 595, pp 343–357, 2007.
  26. Mani, G. S. Sidhu,  R. Kumari,  J. P. Gaddipati,  P. Seth, and R. K. Maheshwari, “Curcumin differentially regulates TGF-beta1, its receptors and nitric oxide synthase during impaired wound healing”,  Biofactors, Vol. 16, pp. 29–43, 2002.
  27. , Ferrari, B. D., Cook, V. Terushkin, G. Pintucci, and P. Mignatti, “Transforming growth factor-beta 1 (TGF-β1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis”, Journal of Cellular Physiology, Vol. 219, pp. 449–458, 2009.
  28. Agrotis, N. Kalinina, and A. Bobik, “Transforming growth factor-β, cell signaling and cardiovascular disorders”, Current Vascular Pharmacology, Vol. 3, pp. 55–61, 2005.
The Research Publication